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A B S T R A C T
BACKGROUND AND PURPOSE: Fluid-attenuated inversion recovery (FLAIR) imaging at 3 Tesla (T) field strength is the
most sensitive modality for detecting white matter lesions in multiple sclerosis. While 7T FLAIR is effective in detecting cortical
lesions, it has not been fully optimized for visualization of white matter lesions and thus has not been used for delineating
lesions in quantitative magnetic resonance imaging (MRI) studies of the normal appearing white matter in multiple sclerosis.
Therefore, we aimed to evaluate the sensitivity of 7T magnetization-transfer-weighted (MTw) images in the detection of white
matter lesions compared with 3T-FLAIR.
METHODS: Fifteen patients with clinically isolated syndrome, 6 with multiple sclerosis, and 10 healthy participants were
scanned with 7T 3-dimensional (D) MTw and 3T-2D-FLAIR sequences on the same day. White matter lesions visible on either
sequence were delineated.
RESULTS: Of 662 lesions identified on 3T-2D-FLAIR images, 652 were detected on 7T-3D-MTw images (sensitivity, 98%; 95%
confidence interval, 97% to 99%). The Spearman correlation coefficient between lesion loads estimated by the two sequences
was .910. The intrarater and interrater reliability for 7T-3D-MTw images was good with an intraclass correlation coefficient (ICC)
of 98.4% and 81.8%, which is similar to that for 3T-2D-FLAIR images (ICC 96.1% and 96.7%).
CONCLUSION: Seven-Tesla MTw sequences detected most of the white matter lesions identified by FLAIR at 3T. This suggests
that 7T-MTw imaging is a robust alternative for detecting demyelinating lesions in addition to 3T-FLAIR. Future studies need to
compare the roles of optimized 7T-FLAIR and of 7T-MTw imaging.
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Introduction
Multiple sclerosis (MS) is a chronic debilitating disease with
a prevalence of 203 cases per 100,000 population in the
UK.1 After the first attack (clinically isolated syndrome [CIS]),
more than 85% of adult-onset patients experience a relapsing-
remitting MS course (RRMS) and 10% have a primary progres-
sive MS.2 Magnetic resonance imaging (MRI) is regarded as
an essential tool for lesion identification and diagnosis,3 esti-
mation of lesion load and disease activity,4 and prediction of
disease outcomes.5 Proton-density-weighted imaging has tradi-
tionally been used to detect MS lesions. Magnetization trans-
fer (MT) sensitizes MR images to the effect of exchange with
macromolecules by off-resonance saturation.6 MT is sensitive to
the integrity of the white matter, due to proton exchange with
macromolecules in myelin.7,8 Often, MT ratio (MTR) maps
are used to improve specificity to MT effects and these are
made by comparing standard images with MT-weighted (MTw)
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
images. However, raw MTw images have greater sensitivity
than processed MTR maps, because they retain some sensitiv-
ity to other contrasts. Here, MTw images are used for lesion
detection, rather than lesion characterization. On MTw images,
abnormal tissue with low myelination is hyperintense with re-
spect to the surrounding white matter tissue. Dousset et al ap-
plied MTw imaging to characterize white matter lesions in MS
and its animal model.9 Pathological correlation studies show
that MT changes reflect decreased myelin content, due to de-
myelination or incomplete remyelination.10 Waesberghe et al
showed better MS lesion delineation using MTw compared to
traditional proton-density images and the number of lesions
was equal.11 MT imaging can monitor both demyelination and
remyelination in patients with MS.12
T2-weighted techniques are sensitive for detecting demyeli-
nating lesions because brain tissue with increased water content
appears hyperintense. T2 fluid-attenuated inversion recovery
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(FLAIR) imaging, an inversion recovery sequence with long T1
to suppress signal from free water (ie, free water appears dark),
is superior to simple T2-weighted imaging for delineating the
interface between cerebrospinal fluid (CSF) (free water) and
normal brain tissue.13 It is sensitive to tissue abnormalities in-
cluding inflammation, edema, demyelination, axonal loss, and
gliosis.14 However, in FLAIR, the detection of brainstem MS
lesions is inferior to T2-weighted imaging because of artifacts
from CSF flow.15 Current clinical guidelines recommend us-
ing T2-FLAIR imaging at 1.5T or 3T to detect lesions in MS
patients, especially in the supratentorial region.16
At 7T, MT with submilliliter imaging resolution enables
detection of MS cortical lesions17 and improves quantitative
assessment of nonlesional “normal appearing” brain tissue.18
Therefore, 7T MT provides high-resolution information on
myelin integrity.
Currently, FLAIR at 7T has the potential to characterize
white matter lesions in MS; however, the sensitivity of le-
sion counts remains challenging. De Graaf et al compared 3-
dimensional (D) FLAIR between 7T and 3T, showing that white
matter lesion counts were higher at 3T, although cortical lesion
counts were higher at 7T.19 Thus, studies showing the superior-
ity of 7T FLAIR are largely restricted to detect cortical rather
than white matter lesions.19,20 To achieve better white matter
lesion detection in FLAIR at 7T, magnetization-prepared 3D-
FLAIR has been developed21,22 and optimized.23 It requires tai-
lored radiofrequency (RF) pulses to alleviate inhomogeneities
inside the RF transmit field while keeping within specific ab-
sorption rate (SAR) constraints, unavailable to us at the time of
this study. To our knowledge, lesion-wise comparison of white
matter MS lesions between magnetization-prepared 3D-FLAIR
at 7T and FLAIR at 3T has not yet been performed.
As the ability to acquire optimized FLAIR imaging at 7T
as described by Saranatan and colleagues23 to detect MS white
matter lesions was lacking at the time of our study, and as
7T FLAIR images obtained without RF optimization provided
unsatisfactory contrast for white matter lesion detection (see
Results section), here we used 3T images instead. Patients par-
ticipating in a 7T MT imaging MRI research study underwent
3T-FLAIR imaging, on the same day.18 The hypothesis of the
study was that the lesion detection rate of supratentorial white
matter in patients with MS is similar between 7T MTw and 3T
FLAIR.
Methods
Patients
Fifteen patients with CIS, 6 with MS, and 10 healthy par-
ticipants were recruited. Patients were assessed with the Ex-
panded Disability Status Scale (EDSS),24 Fatigue Severity Scale
(FSS),25 andMultiple Sclerosis Functional Composite (MSFC)26
by a neurologist (SYL). Patients were recruited from the MS
Clinic, University Hospitals NottinghamNHS Trust. This study
was approved by the local Research Ethics Committee (REC
reference 07/H0408/115). Participants gave written informed
consent.
MR Imaging
Participants underwent MRI in the Sir Peter Mansfield
Imaging Centre (SPMIC) using a 7T Philips Achieva scan-
ner (Philips Medical Systems, Best, the Netherlands). The
scanner is equipped with whole-body gradients, a 16-channel
head-only receive coil, and a head-only volume quadrature
transmit RF coil (Nova Medical, Inc., Wilmington, MA). On
the same day, MR imaging was also performed using a 3T
whole-body MR system (Achieva 3.0 T; Philips) with an eight-
channel head coil for reception (SENSE) and body coil for
transmission.
The area of interest was 15 mm above and below the lon-
gitudinal axis of the corpus callosum. MT images were ac-
quired using a 3D MT-prepared turbo field echo (MT-TFE)
sequence.27,28 Data were acquired first with off-resonance sat-
uration (MTw; signal weighted by the MT effect) and second
without saturation (MTnosat). The saturation was applied as a
train of 20 off-resonance pulses (13.5 µT Gaussian-windowed,
sinc pulses with a bandwidth of 300 Hz, and off-resonance by
±1.05 kHz [3.5 ppm], with 55milliseconds between each pulse).
The acquisition parameters were: field of view = 220 × 220 ×
30 mm3; spatial resolution = .86 × .86 × 1.5 mm3; echo time
(TE) = 5.7 milliseconds; repetition time (TR) = 9.8 millisec-
onds; 20 slices; and total acquisition time 8:22 minutes. Figure 1
shows an example of MTw andMTnosat images. This study used
MTw images (rather thanMTRmaps) as they had higher signal-
to-noise ratio.
The acquisition parameters for 3T-2D-FLAIR sequence
were: 256 × 256 matrix; 50 interleave slices; spatial resolu-
tion 1 × 1 × 3 mm3; TE = 125 milliseconds; inversion time
(TI) = 2,800 milliseconds; TR = 11,000 milliseconds; total ac-
quisition time 5:52 minutes. The acquisition parameters for 7T-
2D-FLAIR sequence were: 192 × 192 matrix; 32 interleave
slices; spatial resolution 1 × 1 × 4 mm3; TE = 100 millisec-
onds; TI = 2,800 milliseconds; TR = 15,000 milliseconds; and
total acquisition time 6 minutes.
The scanning protocols included 3D T1-weighted
magnetization-prepared rapid gradient-echo (MP-RAGE)
imaging to assist with coregistering 3T-2D-FLAIR and 7T-3D-
MTw images. Acquisition parameters at 7T were TE = 3.2
milliseconds; TR = 6.9 milliseconds; TI = 800 milliseconds;
flip angle of the TFE readout pulse = 8o; TFE factor = 240;
shot-to-shot interval = 8 seconds; spatial resolution = 1.25 ×
1.25 × 1.25 mm3; field of view = 200 × 200 × 72.5 mm3;
reconstruction matrix = 160 × 160 × 58; and total acquisition
time 2 minutes.
Image Analysis
Definition of Lesion
White matter lesions were defined as high signal intensity (SI)
compared to background of white matter tissue not attributable
to normal anatomical structures. Lesions were identified and
marked using a consensus approach by two neurologists (IJC
and RT) with experience in MRI analysis. They were blinded
to patient identification and clinical information. The following
were considered normal findings on FLAIR and MTw images:
increased signal in a region of width 2 mm at the anterior
and posterior pole of the lateral ventricles, increased signal in
a strip of width 2 mm at the remainder of the lateral and
third ventricles, symmetrically increased signal in the posterior
limbs of the internal capsule, and any symmetric hyperintensity
suggesting vessel, artifact, or anatomical structure.29,30 If there
was disagreement, a third neurologist (CSC) made the final
consensus decision.
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Fig 1. Axial 7-Tesla 3-dimensional MR images examples of magnetization transfer with no saturation pulse (MTnosat) and magnetization-
transfer-weighted (MTw) in (A) a healthy subject and (B) a 27-year-old male patient with multiple sclerosis (score of the Expanded Disability
Status Scale was 2.0). MTw image (right) shows a better contrast of the gray matter to the white matter, and of white matter lesions to the
normal appearing white matter than MTnosat images (left).
Imaging Postprocessing
Acquired images were coregistered to the 3D-MP-RAGE
image space using FLIRT linear rigid-body image reg-
istration algorithm from the FSL platform (FMRIB)
(www.fmrib.ox.ac.uk/fsl).31 Because of the difference in con-
trast between the original 7T-3D-MTw and 3T-2D-FLAIR scans
and the reference scan, the cost function was the “mutual infor-
mation” with a low number (100) of bins.
Qualitative Assessment: Lesion Count
The white matter lesions on 7T-3D-MTw images were manually
compared to 3T-2D-FLAIR images by a single researcher (IJC).
Figure 2 illustrates the images of the two-step analysis: first,
we did an initial comparison between two images that were
coregistered to the 3D MP-RAGE space. This step identified
lesions in the same neuroanatomical region on both images.
However, since the coregistered images were not perfectly in an
alignment and were downsampled (Fig 2A), we then performed
a retrospective comparison on original 3T-2D-FLAIR and 7T-
3D-MTw images (Fig 2B).
Quantitative Assessment: Lesion Load
To determine the interrater agreement, images of two se-
quences were presented in random order to two neurologists
(IJC and RT). The lesions were outlined using a semiauto-
mated, seed-growing technique using NeuRoi software (Dr.
CR Tench, Clinical Neurology, University of Nottingham, UK;
http://www.nottingham.ac.uk/scs/divisions/clinicalneurology/
software/neuroi.aspx). The total volume of these lesions was
calculated after manual segmentation. To evaluate intrarater
reliability, all images were reassessed by IJC with a delay of
1 week to minimize any memory of the images.32 An
averaged lesion load derived from three assessments per
subject was used for statistical analysis.
Global Image Quality Assessment
All images were evaluated by IJC. Image quality issues such
as lesion detection, motion artifacts, and sharpness of all slices
were rated 0–100, where 0 was perfect and 100 indicated the
need to redo the scanning. Image quality was classified as ex-
cellent (0-30), good (30-70), or blurred (70-100).
The Contrast for Lesions to Normal Appearing White Matter
A total of 50 lesions were arbitrarily selected from different
regions for estimation of the contrast between the SI from
lesions and adjacent or contralateral normal-appearing white
matter (NAWM). The percentage contrast between lesions and
NAWM was calculated according to the following formula:
Contrast = (SIlesion − SINAWM)/(SIlesion + SINAWM) × 100.33
Statistical Analysis
Comparison between the subgroups was performed using
Fisher’s exact test for dichotomized data and Mann-Whitney
U test for continuous data or ordinal clinical rating scales. The
analysis of brain lesions on the different sequences was per-
formed patient-wise. The comparison of the numbers of lesions
on 7T-3D-MTw versus 3T-2D-FLAIRwas expressed as percent-
age gain or a loss in the number of detected brain lesions. The
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Fig 2. The two-step analysis. (A) Step 1: prospective assessment was done after 3-Tesla 2-dimensional-fluid-attenuated inversion recovery
(3T-2D-FLAIR) or 7-Tesla 3-dimensional magnetization-transfer-weighted (7T-3D-MTw) was coregistered to the imaging space of 7-Tesla 3-
dimensional magnetization-prepared rapid gradient echo (voxel dimension of 1.25 × 1.25 × 1.25 mm3). (B) Step 2: retrospective assessment
was performed on the original 3T-2D-FLAIR images (pixel dimension of 1 × 1 mm2, thickness of 3 mm) and 7T-3D-MTw images (voxel
dimension of .86 × .86 × 1.5 mm3). reg = registered.
interobserver agreement in measuring lesion volumes from
both sequences was calculated using intraclass correlation co-
efficient (ICC) with two-sided 95% confidence interval (CI).
Spearman’s rank correlationwas used for correlating lesion load
at 3T-2D-FLAIR and 7T-3D-MTw with clinical scores (EDSS,
FSS, or MSFC). The difference of lesion-to-NAWM contrast
between two sequences was investigated using Student’s t-test.
The two-tailed P-value .05 was considered as a statistically
significant.
Results
Patient Characteristics
We included 15 CIS, 6 MS, and 10 healthy volunteers. Char-
acteristics of these subjects are shown in Table 1. Overall, the
mean age was 36 ± 10 years and 55% of patients were female.
The age and gender were not statistically different between
subgroups. The median EDSS score of patients was 2.5 (in-
terquartile range [IQR], 1.5 to 3.0), median FSS 5.0 (IQR, 2.7
to 5.9), and median MSFC sum score .11 (IQR, −.36 to .42).
Table 1. Baseline Characteristics of Participants
CIS MS Controls
(n = 15) (n = 6) (n = 10)
Median age (IQR) (year) 39 (28-43) 34 (27-54) 35 (25-38)
Female (%) 10 (67%) 4 (67%) 3 (30%)
Median months of disease duration (IQR) 15 (8-24) 65 (28-168)* n.a.
Median EDSS (IQR) 1.5 (1.0-3.0) 3.0 (3.0-3.5)* n.a.
Median FSS (IQR) 4.2 (2.6-5.9) 5.3 (3.6-5.8) n.a.
Median MSFC sum score (IQR) −.12 (−.34 to .41) .23 (−.42 to .43) n.a.
CIS = clinically isolated syndrome; EDSS = Expanded Disability Status Scale; FSS = Fatigue Severity Scale; IQR = interquartile range; MS = multiple sclerosis;
MSFC =Multiple Sclerosis Functional Composite; n = patient number; n.a. = not applicable.
*Statistical significance (P < .05) between patients with CIS and MS.
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Fig 3. Axial 3-Tesla 2-dimensional-fluid-attenuated inversion recovery (3T-2D-FLAIR) (left), 7-Tesla 3-dimensional magnetization-transfer-
weighted (7T-3D-MTw) (middle), and 7T-2D-FLAIR (right) in (A) a healthy participant; (B) a 40-year-old male with clinically isolated syndrome
(score of the Expanded Disability Status Scale [EDSS] was 1.0) with discrete hyperintensities in the deep white matter (arrowhead) and
periventricular white matter (arrow); and (C) a 56-year-old female with multiple sclerosis (score of EDSS was 6.5) with diffuse periventricular
hyperintensities (arrowhead) and juxtacortical hyperintensities (arrow). The white matter lesion delineation is the least optimal on 7T-2D-FLAIR
images.
MRI Findings in Healthy Controls
Figure 3(A) shows an example of 3T-2D-FLAIR and 7T-3D-
MTw images from a healthy participant. In eight healthy
participants, nonspecific discrete hyperintensities were ob-
served in periventricular and deep white matter regions. No
diffuse periventricular hyperintensity or juxtacortical hyperin-
tensity was found in the healthy volunteers.
Sensitivity of White Matter Lesion Detection Using 7T MTw
Images
Figure 3 shows examples of 3T-2D-FLAIR, 7T-3D-MTw, and
7T-2D-FLAIR images. The quality of lesion delineation of 7T-
2D-FLAIR is lower than 3T-2D-FLAIR. Table 2 shows the
sensitivity of lesion detection of 7T-3D-MTw compared to 3T-
2D-FLAIR, and retrospective assessment enhances sensitivity
compared to the initial assessment. Overall, 662 lesions were
identified on original 3T-2D-FLAIR images, and 669 lesions on
original 7T-3D-MTw images. Ten of 662 hyperintensities (1.5%)
in 3T-2D-FLAIR images were not found retrospectively in the
corresponding regions on 7T-3D-MTw images. Seventeen of
669 hyperintensities (2.5%) on 7T-3D-MTw images were not
identified on 3T-2D-FLAIR images. Taking the 3T-2D-FLAIR
images as the gold standard scan, we found a sensitivity of 98%
(95% CI: 97% to 99%) for detecting lesions on the 7T-3D-MTw
images. The sensitivity for detecting lesions on 7T-3D-MTw was
98 % (95% CI: 96% to 99%) for CIS patients (318/325 lesions)
and 99% (95% CI: 98% to 100%) for MS patients (327/329
lesions).
The 27 lesions found by one scan type but not the other
had a maximum diameter <3 mm (Fig 4). Hyperintensities
observed in the basal ganglia on 3T-2D-FLAIR images were
less distinguishable on the corresponding 7T-3D-MTw images
(Fig 4A); most of the hyperintensities observed only on 7T-
3D-MTw images were elongated in the through-plane direc-
tion, and possibly represented perivenous (Virchow-Robin)
spaces.
Intrarater and Interrater Reliability and Comparison of Lesion
Loads
The mean lesion loads in healthy participants, CIS, and MS pa-
tients were 49, 4,996, and 15,102 mm3 for 3T-2D-FLAIR and
24, 2,056, and 6,573 mm3 for 7T-3D-MTw, respectively. The
intrarater reliability was excellent: ICC was 96% (95% CI: 92%
to 98%) for 3T-2D-FLAIR and 98% (95% CI: 97% to 99%) for
7T-3D-MTw. There was strong agreement between two neurol-
ogists: ICC of 98% (95% CI: 93% to 98%) for 3T-2D-FLAIR
and 82% (95% CI: 66% to 91%) for 7T-3D-MTw. Lesion load in
each sequence was highly correlated (correlation .910, P< .001)
(Fig 5). Excluding healthy volunteers, the correlation coefficient
was .875 (P < .001).
The quality of images was rated excellent (= 29, 94%) and
good (n = 2, 6%) for both sequences. The lesion-to-NAWM
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Table 2. Lesion Counts and Sensitivity of the Supratentorial Brain White Matter
Two steps Prospective analysis on registered images Retrospective analysis on original images
Subjects All CIS MS Controls All CIS MS Controls
(n = 31) (n = 15) (n = 6) (n = 10) (n = 31) (n = 15) (n = 6) (n = 10)
3T-2D-FLAIR 634 306 320 8 662 325 329 8
7T-3D-MTw 538 274 258 6 669 329 327 13
Seen on both images 505 250 249 6 652 318 327 7
Sensitivity (%) of
7T-3D-MTw using
3T-2D-FLAIR as the
gold standard (95%
confidence interval)
80 (76-83) 82 (77-86) 78 (73-82) 75 (35–97) 98 (97-99) 98 (96-99) 99 (98-100) 88 (47-100)
The two-step analysis for white matter lesions was applied on 3-Tesla 2-dimensional fluid-attenuated inversion recovery (3T-2D-FLAIR) and 7-Tesla 3-dimensional
magnetization-transfer-weighted (7T-3D-MTw) images.
CIS = clinically isolated syndrome; MS = multiple sclerosis; n = patient number.
Fig 4. Comparison of discrete hyperintensities at the same neu-
roanatomical regions on axial 3-Tesla 2-dimensional-fluid-attenuated
inversion recovery (3T-2D-FLAIR) images (left) and 7-Tesla
3-dimensional magnetization-transfer-weighted (7T-3D-MTw) im-
ages (right). (A) Observable lesion in the basal ganglia (arrowhead)
on 3T-2D-FLAIR only; (B) observable lesion in the deep white matter
on 3T-2D-FLAIR only (arrow); and (C) observable lesion (arrow) in
the deep white matter on 7T-3D-MTw only.
Fig 5. The linear association between lesion loads estimated
by 3-Tesla 2-dimensional-fluid-attenuated inversion recovery (3T-
2D-FLAIR) and by 7-Tesla 3-dimensional magnetization-transfer-
weighted (7T-3D-MTw) images (Spearman Rank correlation, rho =
.910, P < .001).
contrast for 7T-3D-MTw and 3T-2D-FLAIR images was com-
parable (mean ± standard deviation, 27 ± 9% vs. 26 ± 5%).
Clinical Correlation
In patients (n= 21), EDSS correlated with lesion load at 7T-3D-
MTw (rho= .519, P= .016) and 3T-2D-FLAIR (rho= .496, p=
.022). FSS score correlated with the lesion load at 7T-3D-MTw
(rho = .506, P = .019) and 3T-2D-FLAIR (rho = .437, P =
.048). MSFC sum or component scores did not correlate with
lesion load.
Discussion
We assessed the performance of 7T-3D-MTw in detecting le-
sions seen on 3T-2D-FLAIR in patients with CIS or MS. Defin-
ing 3T-2D-FLAIR images as gold standard, we found that
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7T-3D-MTw imaging could detect whitematter lesionswith 98%
sensitivity. The correlation between the lesion loads and EDSS
or fatigue was similar using both images. Therefore, our study
supports a role for 7T-MTw for lesion detection in inflamma-
tory demyelinating conditions. Of note, although lesion count
on both sequences was similar, estimated lesion load on 3T-
2D-FLAIR was almost twice that on 7T-3D-MTw. This may be
related to the increased spatial resolution on 7T-3D-MTw (.86×
.86 × 1.5 mm3) versus 3T-2D-FLAIR (1 × 1 × 3 mm3). It may
also reflect differences in contrast sensitivities, FLAIR being
more sensitive to perilesional edema.34
Seven-Tesla MRI in MS or CIS is known to be safe and
well tolerated,35 and provides high-resolution visualization and
quantification of disease-specific alterations, including myelin
content.1,17,36–41 MTR maps and MTw at 7T can be useful for
detecting intracortical lesions compared to double inversion
recovery (DIR) sequences at 3T.17 Lesion visualization and vol-
ume estimation are better on MTw than MTR map. Because
MTR represents ratios between MT sequences without and
with saturation (MTnosat and MTw) sequentially, patient motion
between the two sequences is not always avoidable. This study
supports the use of 7T-MTw for lesion detection with high sen-
sitivity compared to 3T-FLAIR with the additional benefit that
the MT can be used to quantify the lesion myelin by calculating
MTR (or even estimate the bound proton pool fraction through
quantitative MT scanning) at the same scan session.
Seven-Tesla MRI can provide increased contrast and gen-
erate superior anatomical imaging and disease-specific lesion
assessment compared to 3T.41,42 However, it still presents chal-
lenges.Whereas T1- or T2*-weighted scans are nowwidely used
at 7T, T2-weighted FLAIR imaging remains limited, particu-
larly for noncortical lesions, because of RF inhomogeneity ef-
fects and increased SAR, and lengthened gray and white mater
T1 relaxation times (meaning that signals are not fully recovered
at the inversion time when CSF signal is nulled). Despite efforts
to overcome these issues, current FLAIR imaging at 7T shows
variations in the transmit field causing regional hypointensity
throughout the brain, particularly in the temporal lobes,43 het-
erogeneous CSF suppression,22 and long acquisition times.23
Our study shows that while 3D-MTw imaging is technically
more straightforward than 7T FLAIR, it shows similar white
matter lesion detection rate to 3T-2D-FLAIR, while providing
additional information on the myelin content,12 useful for lon-
gitudinal or cross-sectional studies. MTw imaging did not detect
10 (1.5%) hyperintensities observed on 3T-2D-FLAIR images
and detected 17 (2.5%) hyperintensities that were not visualized
on 3T-2D-FLAIR. These minor differences may be attributed
to the fact that MTw images have a smaller imaging resolution
and the sequence is more sensitive to pathological changes re-
lated to macromolecular-bound protons than FLAIR images,
as shown in brain abscesses44 or tuberculoma.45
Some limitations of the current study deserve discussion.
First, we only included supratentorial regions. Demyelinating
lesions in MS or CIS occur most frequently in periventricular
regions, and were captured in our study. The visibility of lesions
in the temporal lobes and cerebellum needs further evaluation,
as 7T transmit RF field inhomogeneity is high in these regions.
Second, caution is needed in directly comparing estimates of
lesion volumes on 3T-2D-FLAIR and 7T-3D-MTw images as
acquisition and resolution were different. The acquisition pro-
tocol was 3D for 7T MTw and 2D for 3T FLAIR, with images
registered to 3D MP-RAGE images that may affect the results
(eg, sensitivity to motion). The measured lesion load in 7T-3D-
MTw correlated with EDSS and fatigue in a similar manner to
that in 3T-2D-FLAIR, which is remarkable for this small num-
ber of patients. Third, the sample size was relatively small and
most patients enrolled in this study, primarily aimed at explor-
ing quantitative changes in early demyelinating disease, had
short disease duration. However, for the purposes of validating
7T-3D-MTw for lesion detection and delineation, short duration
is an advantage, fewer lesions being confluent. Fourth, we did
not analyze cortical lesions, which require different but more
sophisticated techniques.17 Indeed, 7T FLAIR may be superior
for cortical lesions.19 Fifth, imaging inhomogeneity at 7T may
be controlled to some extent by using multitransmit technology
that was not available in this study. Furthermore, a direct com-
parison between 7T FLAIR and 7T MTw is desirable but at the
time the optimized 7T FLAIR was not acquired for research
quality analysis due to unresolved technical issues (mentioned
above). Such a study in the future, using optimized 7T FLAIR,
may well show this sequence to be more sensitive in detect-
ing white matter lesions than both 7T MTw and 3T FLAIR. In
the absence of such optimized 7T FLAIR, however, 7T MTw
appears to be a reliable sequence for white matter lesions.
Conclusions
MTw imaging at 7T allows evaluation and assessment of supra-
tentorial lesions with similar white matter lesion detection to 3T
FLAIR images in patients with CIS or MS. The results support
the application of MTw imaging at 7T in the detection and vol-
ume estimation of demyelinating lesions as a reliable substitute
for FLAIR imaging. However, a prospective study to compare
white matter lesion detection between optimized 7T FLAIR,
7T MTw, and 3T FLAIR at the same imaging resolution and
dimension will help determine the most sensitive sequence for
white matter lesions at 7T.
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